Quarterly 13F snapshot: US-listed longs only, no performance figures — 13F data cannot support them.
Reported portfolio value by quarter (4 quarters reported)
$192M in Q4 2021 → $144M now. Hover for any quarter.
As reported for the quarter ended September 30, 2022. Activity is the change in share count since the prior quarter's filing.
| Holding | % of portfolio | Activity | Shares | Value |
|---|---|---|---|---|
| Eqrx, Inc. | 60.1% | Unchanged | 17,438,465 | $86.3M |
| Nautilus Biotechnology, Inc. | 24.1% | Unchanged | 16,298,006 | $34.6M |
| Erasca, Inc. | 13.6% | Unchanged | 2,500,000 | $19.5M |
| Invitae Corporation | 2.2% | Added 9.1% | 1,276,541 | $3.14M |
What changed each quarter, from the filings' own share counts. Largest moves first; most recent 3 quarters.
quarter ended September 30, 2022 · filed November 14, 2022
| Company | Action | Shares changed | Value of change | % of portfolio |
|---|---|---|---|---|
| Invitae Corporation | Added | +106,414 | +$262K | 2.2% |
quarter ended June 30, 2022 · filed August 15, 2022
No position changes this quarter.
quarter ended March 31, 2022 · filed May 16, 2022
No position changes this quarter.
Loading...
